| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,036 |
15,215 |
$699K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,098 |
3,751 |
$173K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,079 |
2,004 |
$172K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,076 |
2,020 |
$171K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,903 |
1,841 |
$149K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,036 |
5,708 |
$145K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,151 |
1,095 |
$86K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,801 |
3,358 |
$81K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,033 |
2,823 |
$81K |
| 99429 |
|
1,683 |
1,620 |
$54K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
884 |
825 |
$46K |
| 99000 |
|
2,699 |
2,497 |
$27K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
417 |
341 |
$26K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,019 |
3,612 |
$25K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,671 |
2,053 |
$22K |
| 36410 |
|
1,403 |
1,284 |
$19K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,601 |
1,309 |
$15K |
| S8301 |
Infection control supplies, not otherwise specified |
1,242 |
1,143 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
878 |
789 |
$10K |
| 90461 |
|
2,462 |
2,005 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
639 |
602 |
$8K |
| 0002A |
|
189 |
174 |
$7K |
| 0001A |
|
220 |
174 |
$6K |
| 0071A |
|
112 |
109 |
$4K |
| 0072A |
|
98 |
96 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
370 |
355 |
$3K |
| 81002 |
|
992 |
928 |
$3K |
| 99050 |
|
140 |
130 |
$2K |
| 86580 |
|
226 |
218 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
26 |
26 |
$2K |
| 0053A |
|
40 |
35 |
$1K |
| 87807 |
|
117 |
108 |
$1K |
| 96160 |
|
530 |
509 |
$1K |
| 97169 |
|
13 |
13 |
$650.00 |
| 99051 |
|
28 |
24 |
$313.74 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
426 |
389 |
$235.48 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
27 |
25 |
$189.50 |
| 90715 |
|
108 |
101 |
$124.28 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
59 |
47 |
$73.38 |
| 84030 |
|
13 |
13 |
$50.82 |
| 90620 |
|
253 |
238 |
$10.06 |
| 90686 |
|
820 |
791 |
$0.23 |
| 90677 |
|
242 |
223 |
$0.20 |
| 90651 |
|
409 |
391 |
$0.13 |
| 90619 |
|
147 |
142 |
$0.09 |
| 90671 |
|
56 |
55 |
$0.01 |
| 90697 |
|
620 |
585 |
$0.00 |
| 90698 |
|
145 |
144 |
$0.00 |
| 90696 |
|
58 |
57 |
$0.00 |
| 90744 |
|
46 |
46 |
$0.00 |
| 91307 |
|
256 |
238 |
$0.00 |
| 91305 |
|
87 |
72 |
$0.00 |
| 90633 |
|
444 |
437 |
$0.00 |
| 90681 |
|
355 |
335 |
$0.00 |
| 90700 |
|
27 |
27 |
$0.00 |
| 90710 |
|
319 |
312 |
$0.00 |
| 90670 |
|
876 |
842 |
$0.00 |
| 90734 |
|
269 |
256 |
$0.00 |
| 91300 |
|
471 |
377 |
$0.00 |
| 90648 |
|
14 |
14 |
$0.00 |